Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RYTELO safely and effectively. See full prescribing information for RYTELO. RYTELO® (imetelstat) for injection, for intravenous use. Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
RYTELO is indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).
- generic_name
- imetelstat sodium
- product_names
- imetelstat sodium
- ndc
- 82959-112, 82959-112-01, 82959-111, 82959-111-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en